Since GRACE was established in 2005, women’s experiences of all five gynaecological cancers have been at the heart of everything we do.
GRACE was founded to answer the questions that affect women’s likelihood of surviving their cancer – but also how we can improve the quality of their life beyond a diagnosis.
The entire GRACE Team is committed to pushing forward improvements in treatment, recovery and survival rates for women diagnosed with any of the five gynaecological cancers. Now and in the future.
WHY WE’RE HERE
In the UK, 21,000 women are diagnosed with a gynaecological cancer every year. This is 58 women diagnosed every day, and 21 of these will die.
GRACE is dedicated to research which will improve the treatment, recovery, and survival rates of women diagnosed in the future, and are currently involved in several projects including investigation of chemotherapy resistant ovarian cancers. Its findings feed into the wider UK network, helping to influence and shape the diagnosis and treatment of these women.